Skip to Content
 
Center for International Blood and Marrow Transplant Research

HS18-01

Main Content

International collaborative study to compare the prognosis for acute leukemia patients transplanted with intensified myeloablative regimens.

Study #: HS18-01

Study Status: Published

Presentation(s)

2022, ASH (Poster)

Efficacy of TBI-based intensified myeloablative regimens for acute leukemia – an international collaborative study.

Citation

Arai Y, Brazauskas R, He N, Al-Homsi AS, Chhabra S, Battiwalla M, Yanada M, Steinberg A, Diaz Perez MA, Hong S, Kanda J, Bashey A, Frangoul HA, Badawy SM, Verdonck LF, Lazarus HM, Yared JA, Hashem H, Sharma A, Aljurf M, Dias AL, Abid MB, Wirk B, Freytes CO, Zeidan AM, Gergis U, Beitinjaneh A, Askar M, Pu JJ, Lehmann LE, Rangarajan HG, Wood WA, Hashmi S, Yano S, Kako S, Ozawa Y, Doki N, Kanda Y, Fukuda T, Katayama Y, Ichinohe T, Tanaka J, Teshima T, Okamoto S, Atsuta Y, Saber W.

EJHaem. 2025, May 28: 6(3): 6(3):e70061. doi: 10.1002/jha2.70061. Epub 2025, May 28. PMCID:PMC12118588.

PubMed

PMID: 40438703

Abstract